mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.6 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |